MSH6 and colorectal carcinoma: LS patients with prior CRC had a risk of metachronous CRC that was similar to the risk of a first CRC for path_MLH1 carriers and a risk of metachronous CRC that was higher than the risk of a first CRC for path_MSH2 and path_MSH6 carriers.